Ejaculatory and Orgasmic Dysfunction Registry
This observational study is creating a national registry to understand how different treatments work for men experiencing ejaculatory dysfunction (problems with ejaculation) or anorgasmia (difficulty reaching orgasm). The study aims to collect information on the safety and effectiveness of various therapies. You can join if you are a man being treated for these conditions, or if you are the sexual partner of a man receiving such treatment. The main goal is to track outcomes over 3 years by having participants complete questionnaires about their diagnosis and treatment success. The current status of the study is unclear.
- Study design
- This is an observational study aiming to enroll 500 participants. It is designed as a registry to collect information on treatments for ejaculatory and orgasmic dysfunction.
- What's involved
- You would complete questionnaires at the start of the study, then every 3 months for the first year, and every 6 months for the next two years.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for a total of 3 years, with the primary objective measured at this time.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Ejaculatory and Orgasmic Dysfunction Registry
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Primary Objective3 years
Report subjective efficacy of therapies used to treat ejaculatory dysfunction. Study participants will have the option of indicating if they had used any treatments to treat ejaculatory disorders. If so, they will then be asked to measure its efficacy at improving their symptoms using a 1-10 scale (10 being very effective).